Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar blackbodypie (36.37) Submitted: 8/17/2012 1:41:27 PM : Outperform Start Price: $8.15 ARNA Score: +14.30

tsif

Featured Broker Partners


Advertisement